Anridia Europe

What Anridia Europe does

Aniridia Europe is a non-profit federation founded in 2011 and headquartered in Sandefjord, Norway, that unites 13 national aniridia associations plus support groups and contact persons in 20 additional European countries to support individuals affected by aniridia, a rare genetic eye disorder. The federation addresses the isolation that arises from the disease's extreme rarity by coordinating cross-border information sharing, community building, and access to specialized clinical expertise across Europe.

The organization's core offerings consist of resource libraries (a multilingual scientific literature database and a clinical guidelines repository featuring European COST action ANIRIDIA-NET guidelines alongside national protocols), educational materials for families and schools, the biennial European Aniridia Conference (EAC) — the 7th edition in Stockholm (2024) drew 180 participants — and the European Aniridia Leadership & Collaboration Academy (EALCA) for emerging leaders. Aniridia Europe also participates as a patient representative in European Commission and Erasmus+ funded research and social inclusion projects, including AAK-INSIGHT (€1.4M, 2021–2023), Restore Vision (2023–2027), COST Action Aniridia-Net, and multiple Erasmus+ inclusion initiatives. The underlying technology is a lightweight web platform comprising a multilingual website, email newsletter, YouTube/Facebook/Instagram channels, and online meeting tools used by volunteer coordinators.

The business model is that of a federation-funded NGO. Aniridia Europe does not receive government funding for its core operations and relies on individual donations, sponsor contributions (e.g., PTC Therapeutics), fundraising campaigns, and modest membership fees from national associations. Project-based grant income flows to the broader research consortia in which the federation participates; Aniridia Europe's role is typically as Patient Advisory Board member or patient community bridge rather than primary grant recipient. All patient-facing services are provided free of charge.

Name

Anridia Europe

Legal name

Aniridia Europe

Website

https://aniridia.eu

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

Aniridia Europe is a non-profit federation of 13 national aniridia associations serving people with the rare genetic eye disorder aniridia across 33+ European countries through clinical guidelines, research project participation, biennial conferences, and leadership development programs.

Ownership category

akta.pro rank

Product category

Rare Disease Patient Advocacy

NAICS

Business Associations (813910), Professional Organizations (813920), Civic and Social Organizations (813410)

SIC

Services-Membership Organizations (8600), Services-Social Services (8300)

akta.pro primary industry

Technical Committees, Working Groups & Expert Panels (BPADANAB)

Keywords

• Rare disease advocacy
• Patient federation services
• Aniridia community support
• Genetic eye disorder resources
• Rare disease conferences

Headquarters

HQ city

Sandefjord

HQ country

Norway

HQ region

Europe

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Donations and Fundraising: As an NGO without government funding, Aniridia Europe relies on donations from individuals, sponsors, and fundraising campaigns to finance activities including conferences, projects, and member support.
2. Membership Fees: National associations pay membership fees to the federation, though the current fee structure was maintained as it is affordable for member organizations.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Core offering

Aniridia Europe is a federation of European national aniridia associations that supports people with aniridia, a rare genetic eye disorder, and their families. Its core offerings are a scientific literature database, a clinical guidelines repository, the biennial European Aniridia Conference series, and the European Aniridia Leadership & Collaboration Academy (EALCA), coordinated across 13 national member associations in 33+ European countries.

Product overview

Aniridia Europe is a federation of European aniridia associations that operates as a non-profit patient organization rather than a commercial technology company. Its core offerings consist of resource libraries (scientific literature database and clinical guidelines repository), educational materials (sports guidelines, school tools), and organized events (European Aniridia Conferences, Leadership Academy). The organization also coordinates multiple European research projects including Restore Vision, Aniridia-Net COST Action, and various Erasmus+ social inclusion initiatives targeting low vision individuals.

Differentiator

Problem solved

Functional benefit

Products and services

• Scientific Literature Database A comprehensive collection of academic monographic studies and medical articles published in scientific journals on aniridia, listed in reverse chronological order with abstracts and links to original articles. It is targeted at medical professionals, researchers, and students.
• Clinical Guidelines Repository A collection of clinical guidelines on aniridia including European COST action ANIRIDIA-NET guidelines, Italian guidelines, Spanish guidelines, and French protocols for diagnosis and care of aniridia and WAGR syndrome. Targeted at ophthalmologists, geneticists, and clinical teams.
• European Aniridia Conferences (EAC) Scientific conferences bringing together clinicians, researchers, patient organisations and members of the aniridia community for scientific exchange, collaboration and networking. The 7th EAC was held in Stockholm on May 31-June 2, 2024 and the 8th EAC is scheduled for Sofia, Bulgaria on April 17, 2026.
• European Aniridia Leadership & Collaboration Academy (EALCA) Academy designed to develop leadership skills, confidence and connections needed to strengthen the global aniridia community, held alongside European Aniridia Conferences for young people and emerging leaders aged 18-30.
• Sports and Visual Impairment Guidelines Brochure on theoretical basics and practical indications for physical activity and adapted sports for the blind and visually impaired, directed to families, teachers and coaches of children and adults with aniridia.
• AAK-INSIGHT Research Project Three-year EU-funded research project (2021-2023) with 1.4 million Euro budget to find a drug able to induce PAX6 protein production in the eye and cornea. Aniridia Europe participated on the Patient Advisory Board bridging patients and scientists.
• Aniridia-Net COST Action (CA18116) European Cooperation in Science and Technology funded program building pan-European collaboration within the aniridia community to improve clinical management of aniridia and advance research in cornea, stem cells, genetics, and regenerative medicine. Funded by Horizon 2020 Framework Programme.
• Restore Vision Project European Commission funded project (2023-2027) developing and testing new treatments for 7 rare eye diseases including aniridia by repurposing existing generic drugs, developing new therapeutic compounds, and conducting pioneering clinical trials. Aniridia Europe bridges patient communities and scientists.

Quantifiable outcome

• 13 national associations + support groups in 20 European countries connected through the federation
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Ten partnerships are on record, tiered core, minor and major.

• Asociación Española de Aniridia (AEA)coreStrategic or Co-development Partner · 1 January 2025Spanish national association and founding member of Aniridia Europe. Awarded €12,000 research grant to IMO Miranza for CRISPR-based gene therapy research project led by Dr. Esther Pomares.
• Dr Shroff's Charity Eye Hospital, IndiaminorGTM or Marketing Partner · 1 January 2024Participation in CURED initiative webinar 'Hope for Rare Eye Diseases' organized by Dr Shroff's Charity Eye Hospital in New Delhi, India. Aniridia Europe contributed as speaker to promote international awareness and collaboration on rare eye diseases.
• Restore Vision ConsortiumcoreStrategic or Co-development Partner · 1 January 2023European Commission funded project (2023-2027) developing and testing new treatments for 7 rare eye diseases including aniridia. Consortium joins 10 European key players on rare eye diseases led by University of Galway. Aniridia Europe plays active role as bridge between patient communities and scientists.
• Erasmus+ Together For Inclusion ConsortiummajorStrategic or Co-development Partner · 1 January 2023Erasmus+ funded project (2023-2024) enhancing inclusion of individuals with low vision worldwide through associationism. Partners include RedTree (Spain), ALBA (Spain), Aniridia Italiana, Simplymente Amigos (Spain), Albinos Chile, and others.
• Erasmus+ Seeing the Invisible ConsortiummajorStrategic or Co-development Partner · 1 January 2022Erasmus+ project (2022-2024) developing digital and adapted tools for inclusion of students with low vision in school education. Project led by RedTree with partners including ALBA, Aniridia Europe, Aniridi Norge, Aniridia Italiana, and SmallCodes (Italy).
• AAK-INSIGHT ConsortiummajorStrategic or Co-development Partner · 1 January 2021EU funded project (2021-2023) with 1.4 million Euro budget developing drug to induce PAX6 protein production in the eye. Led by Prof. Neil Lagali (Linköping University) and Prof. Daniel Aberdam (CNRS). Aniridia Europe in Patient Advisory Board along with member associations.
• COST Action Aniridia-Net (CA18116/CA181169)coreStrategic or Co-development Partner · 1 January 2019European Cooperation in Science and Technology funded program building pan-European collaboration within aniridia community. Aniridia Europe represents patients and plays active role. Funded by Horizon 2020 Framework Programme. Key achievements include European clinical guidelines publication.
• EURORDIScoreStrategic or Co-development PartnerAniridia Europe partners with EURORDIS (The voice of rare disease patients in Europe), a non-governmental alliance of patient organizations representing over 900 rare disease patient organizations across Europe. This partnership connects Aniridia Europe with the broader rare disease community and advocacy efforts.
• European Reference Network on Rare Eye Diseases (ERN-EYE)coreStrategic or Co-development PartnerAniridia Europe participates in ERN-EYE through volunteer representation (Oana Simerea from Romania), connecting the aniridia patient community with European reference networks for rare eye diseases.
• PTC TherapeuticsminorGTM or Marketing PartnerListed as sponsor on Aniridia Europe website, supporting the mission and objectives of the federation through generous donations.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• National Organization for Rare Disorders (NORD): US federation of ~300 rare disease patient organizations offering the analogous national-level model (membership federation, conferences, research advocacy) that Aniridia Europe replicates at the European scale.
• Retina International: Umbrella federation of national retinal disease patient organizations with comparable European scope, conference cadence, and researcher/patient convening mission in the rare eye disease space.
• EURORDIS – Rare Diseases Europe: European alliance of 900+ rare disease patient organizations; Aniridia Europe is a listed member/partnership and sits inside the same umbrella ecosystem for rare disease advocacy, policy engagement, and EURORDIS-led EU project participation.
• Asociación Lucha Contra la Ceguera (ALBA): Spanish low-vision patient association and close Erasmus+ partner of Aniridia Europe on the Together For Inclusion and Seeing the Invisible consortia — directly co-delivering European inclusion projects for visually impaired people.

Others

• Orphanet: European reference portal for rare diseases and orphan drugs, co-funded by the EU; overlaps with Aniridia Europe on rare disease information dissemination, classification, and EU policy infrastructure for aniridia.

Broad incumbents

• European Patients' Forum (EPF): EU-level umbrella of chronic disease patient organizations with policy/training/advocacy programs analogous to Aniridia Europe's EALCA leadership academy and EURORDIS engagement; broader remit but directly relevant peer.
• European Blind Union (EBU): Pan-European federation representing blind and partially sighted people; comparable continental advocacy and conference model but with broader (low-vision) remit versus Aniridia Europe's single-condition focus.
• Fondation Rare Diseases / Rare Disease Foundation (FRB): French national umbrella for rare disease research and patient support; comparable governance/funding model (NGO + EU/public grants + member associations) and adjacent scope to Aniridia Europe's pan-European mission.
• European Reference Network for Rare Eye Diseases (ERN-EYE): EU-funded supranational clinical network for rare eye diseases including aniridia; Aniridia Europe already has volunteer representation (Oana Simerea) inside ERN-EYE, making it both a peer and a public-sector counterpart.

Regional players

• Canadian Organization for Rare Disorders (CORD): Canada's national rare-disease patient federation; operates the same membership-of-associations, conference, and policy-advocacy model, but serves a single non-European country.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/user/AniridiaEurope
• Facebookfacebook.com/AniridiaEurope
• Instagraminstagram.com/aniridia_europe
• Xx.com/AniridiaEurope
• LinkedInlinkedin.com/company/aniridiaeurope

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Anridia Europe